Anderson VR, Jason LA, Hlavaty LE A qualitative natural history study of ME/CFS in the community. Health Care Women Int. 2014 Jan;35(1):3-26. doi: 10.1080/07399332.2012.684816. Epub 2013 Feb 27.
Baker R, Shaw EJ Diagnosis and management of chronic fatigue syndrome or myalgic encephalomyelitis (or encephalopathy): summary of NICE guidance. BMJ. 2007 Sep 1;335(7617):446-8. doi: 10.1136/bmj.39302.509005.AE. No abstract available.
Beard DD Chronic fatigue syndrome clinical practice guidelines: psychological factors. Med J Aust. 2002 Nov 4;177(9):526; author reply 526-7. doi: 10.5694/j.1326-5377.2002.tb04937.x. No abstract available.
Beaver WL, Wasserman K, Whipp BJ A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol (1985). 1986 Jun;60(6):2020-7. doi: 10.1152/jappl.1986.60.6.2020.
Borg GA Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14(5):377-81.
Cairns R, Hotopf M A systematic review describing the prognosis of chronic fatigue syndrome. Occup Med (Lond). 2005 Jan;55(1):20-31. doi: 10.1093/occmed/kqi013.
Ciccolella ME, Boone T, Davenport T Part II. Legal aspects of aerobic capacity: objective evidence of the ability to work. PEPonline. 2011 septiembre; 14 (9): 11. In: https://www.asep.org/asep/asep/Part%20II%20Legal%20MARGARET%20CICCOLELLA.pdf.
Datta D, Normandin E, ZuWallack R Cardiopulmonary exercise testing in the assessment of exertional dyspnea. Ann Thorac Med. 2015 Apr-Jun;10(2):77-86. doi: 10.4103/1817-1737.151438.
Davenport TE, Stevens SR, Baroni K, Van Ness JM, Snell CR Reliability and validity of Short Form 36 Version 2 to measure health perceptions in a sub-group of individuals with fatigue. Disabil Rehabil. 2011;33(25-26):2596-604. doi: 10.3109/09638288.2011.5
Engleberg N Síndrome de fatiga crónica. En: Mandell GL, Bennett JE, Dolin R, editores, Douglas RG, colaborador. Mandell, Douglas, y Bennett. Enfermedades Infecciosas: principios y práctica. 5ª ed. Buenos Aires: Ed. Panamericana, 2002. p.1871-1877.
Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med. 1994 Dec 15;121(12):953-9. doi: 10.7326/0003-4819-121-12-199412150-00009.
Hardt J, Buchwald D, Wilks D, Sharpe M, Nix WA, Egle UT Health-related quality of life in patients with chronic fatigue syndrome: an international study. J Psychosom Res. 2001 Aug;51(2):431-4. doi: 10.1016/s0022-3999(01)00220-3.
Klimas N, Patarca R Disability and chronic fatigue syndrome: clinical, legal and patient perspectives. Binghamton NY: Haworth Medical Press; 1997.
Lewis I, Pairman J, Spickett G, Newton JL Clinical characteristics of a novel subgroup of chronic fatigue syndrome patients with postural orthostatic tachycardia syndrome. J Intern Med. 2013 May;273(5):501-10. doi: 10.1111/joim.12022. Epub 2013 Jan 7.
Make B, Jones JF Impairment of patients with chronic fatigue syndrome. J Chronic Fatigue Syndr. 1997;3(4):43-56.
Nijs J, Demol S, Wallman K Can submaximal exercise variables predict peak exercise performance in women with chronic fatigue syndrome? Arch Med Res. 2007 Apr;38(3):350-3. doi: 10.1016/j.arcmed.2006.10.009. Epub 2007 Jan 30.
Nijs J, Ickmans K Postural orthostatic tachycardia syndrome as a clinically important subgroup of chronic fatigue syndrome: further evidence for central nervous system dysfunctioning. J Intern Med. 2013 May;273(5):498-500. doi: 10.1111/joim.12034. Epub 2013 Feb 8. No abstract available.
Pankoff B, Overend T, Lucy D, White K Validity and responsiveness of the 6 minute walk test for people with fibromyalgia. J Rheumatol. 2000 Nov;27(11):2666-70.
Ratter J, Radlinger L, Lucas C Several submaximal exercise tests are reliable, valid and acceptable in people with chronic pain, fibromyalgia or chronic fatigue: a systematic review. J Physiother. 2014 Sep;60(3):144-50. doi: 10.1016/j.jphys.2014.06.011.
Richardson RD, Engel CC Jr Evaluation and management of medically unexplained physical symptoms. Neurologist. 2004 Jan;10(1):18-30. doi: 10.1097/01.nrl.0000106921.76055.24.
Ryan CG, Grant PM, Tigbe WW, Granat MH The validity and reliability of a novel activity monitor as a measure of walking. Br J Sports Med. 2006 Sep;40(9):779-84. doi: 10.1136/bjsm.2006.027276. Epub 2006 Jul 6.
Sargent C, Scroop GC, Nemeth PM, Burnet RB, Buckley JD Maximal oxygen uptake and lactate metabolism are normal in chronic fatigue syndrome. Med Sci Sports Exerc. 2002 Jan;34(1):51-6. doi: 10.1097/00005768-200201000-00009.
Sharpe M The report of the Chief Medical Officer's CFS/ME working group: what does it say and will it help? Clin Med (Lond). 2002 Sep-Oct;2(5):427-9. doi: 10.7861/clinmedicine.2-5-427.
Snell CR, Stevens SR, Davenport TE, Van Ness JM Discriminative validity of metabolic and workload measurements for identifying people with chronic fatigue syndrome. Phys Ther. 2013 Nov;93(11):1484-92. doi: 10.2522/ptj.20110368. Epub 2013 Jun 27.
Stewart JM, Medow MS, Messer ZR, Baugham IL, Terilli C, Ocon AJ Postural neurocognitive and neuronal activated cerebral blood flow deficits in young chronic fatigue syndrome patients with postural tachycardia syndrome. Am J Physiol Heart Circ Physiol. 2012 Mar 1;302(5):H1185-94. doi: 10.1152/ajpheart.00994.2011. Epub 2011 Dec 16.
Strahler J, Fischer S, Nater UM, Ehlert U, Gaab J Norepinephrine and epinephrine responses to physiological and pharmacological stimulation in chronic fatigue syndrome. Biol Psychol. 2013 Sep;94(1):160-6. doi: 10.1016/j.biopsycho.2013.06.002. Epub 2013 Jun 13.
Taylor RR, O'Brien J, Kielhofner G, Lee SW, Katz B, Mears C The occupational and quality of life consequences of chronic fatigue syndrome/myalgic encephalomyelitis in young people. Br J Occup Ther. 2010 Nov 1;73(11):524-530. doi: 10.4276/030802210X12892992239233.
Turnbull N, Shaw EJ, Baker R, Dunsdon S, Costin N, Britton G, et al National Institute for Health and Clinical Excellence. Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy): diagnosis and management of CFS/ME in adults and children. London: Royal College of General Practitioners; 2007. In: http://guidance.nice.org.uk/CG053
Twisk FN Accurate diagnosis of myalgic encephalomyelitis and chronic fatigue syndrome based upon objective test methods for characteristic symptoms. World J Methodol. 2015 Jun 26;5(2):68-87. doi: 10.5662/wjm.v5.i2.68. eCollection 2015 Jun 26.
Twisk FN The status of and future research into Myalgic Encephalomyelitis and Chronic Fatigue Syndrome: the need of accurate diagnosis, objective assessment, and acknowledging biological and clinical subgroups. Front Physiol. 2014 Mar 27;5:109. doi: 10.3389/fphys.2014.00109. eCollection 2014.
Watz H, Waschki B, Meyer T, Magnussen H Physical activity in patients with COPD. Eur Respir J. 2009 Feb;33(2):262-72. doi: 10.1183/09031936.00024608. Epub 2008 Nov 14. Erratum In: Eur Respir J. 2010 Aug;36(2):462.
World Health Organization International statistical classi?cation of diseases and related health problems. 10th revision. Fifth edition. 2016. [internet]. Ginebra: World Health Organization; 2016. In: http://apps.who.int/classifications/icd10/browse/2016/en.
Assessment of Exercise Response in Chronic Fatigue Syndrome / Myalgic Encephalomyelitis.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.